España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
argenx
ARGX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$623.82
-2.21
-0.35%
At close: -
$623.82
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
argenx (ARGX) Forecast
News
Earnings
argenx (ARGX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for argenx (NASDAQ:ARGX) Stock
argenx Stock (NASDAQ: ARGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
Wells Fargo Maintains Overweight on argenx, R...
Benzinga Newsdesk
Wednesday, December 18, 2024
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Tuesday, December 17, 2024
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
Vandana Singh
Monday, December 09, 2024
Looking Into argenx's Recent Short Interest
Benzinga Insights
Thursday, November 21, 2024
Oppenheimer Reiterates Outperform on argenx, ...
Benzinga Newsdesk
Evercore ISI Group Maintains Outperform on ar...
Benzinga Newsdesk
Wednesday, November 20, 2024
HC Wainwright & Co. Reiterates Buy on argenx,...
Benzinga Newsdesk
Argenx shares are trading higher after the co...
Benzinga Newsdesk
argenx Pushes Efgartigimod SC Forward: Phase ...
Benzinga Newsdesk
Thursday, November 14, 2024
(ARGX) - Analyzing argenx's Short Interest
Benzinga Insights
Tuesday, November 12, 2024
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Wolfe Research Upgrades argenx to Outperform,...
Benzinga Newsdesk
Monday, November 11, 2024
argenx And Zai Lab Announce China's National ...
Benzinga Newsdesk
Wednesday, November 06, 2024
Peering Into argenx's Recent Short Interest
Benzinga Insights
Tuesday, November 05, 2024
Argenx shares are trading higher after Scotia...
Benzinga Newsdesk
This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Scotiabank Upgrades argenx to Sector Outperfo...
Benzinga Newsdesk
Monday, November 04, 2024
JP Morgan Maintains Overweight on argenx, Rai...
Benzinga Newsdesk
Friday, November 01, 2024
Guggenheim Maintains Buy on argenx, Raises Pr...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on argenx, R...
Benzinga Newsdesk
Argenx shares are trading higher. Multiple fi...
Benzinga Newsdesk
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
Hayden Buckfire
This Atlassian Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Avi Kapoor
This Huntington Ingalls Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Avi Kapoor
Truist Securities Maintains Buy on argenx, Ra...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on argenx,...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on argenx, R...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
William Blair Upgrades argenx to Outperform
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on argenx, ...
Benzinga Newsdesk
Baird Downgrades argenx to Neutral, Raises Pr...
Benzinga Newsdesk
Thursday, October 31, 2024
Truist Securities Maintains Buy on argenx, Ra...
Benzinga Newsdesk
Argenx shares are trading higher after the co...
Benzinga Newsdesk
argenx Q3 2024 GAAP EPS $1.39 Beats $0.02 Est...
Benzinga Newsdesk
Thursday, October 17, 2024
The Latest Analyst Ratings For argenx
Benzinga Insights
Citigroup Maintains Buy on argenx, Raises Pri...
Benzinga Newsdesk
Tuesday, October 15, 2024
argenx Highlights Patient Impact Data Across ...
Benzinga Newsdesk
Thursday, October 10, 2024
Raymond James Reinstates Strong Buy on argenx...
Benzinga Newsdesk
Thursday, September 26, 2024
Peeling Back The Layers: Exploring argenx Through Analyst Insights
Benzinga Insights
Guggenheim Reiterates Buy on argenx, Maintain...
Benzinga Newsdesk
Tuesday, September 24, 2024
Snowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Thursday, September 19, 2024
argenx's ADHERE Study Published In The Lancet...
Benzinga Newsdesk
Thursday, August 29, 2024
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Vandana Singh
Friday, August 23, 2024
What 25 Analyst Ratings Have To Say About argenx
Benzinga Insights
JP Morgan Maintains Overweight on argenx, Rai...
Benzinga Newsdesk
Monday, August 12, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, August 06, 2024
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Barclays Upgrades argenx to Overweight
Benzinga Newsdesk
Monday, July 29, 2024
The Analyst Verdict: argenx In The Eyes Of 27 Experts
Benzinga Insights
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch